Praxis Precision Medicines, Inc. (PRAX) Revenue History
Annual and quarterly revenue from 2018 to present
PRAX Revenue Over Time (2018–2025)
PRAX Revenue Growth History
1 of 2 years with positive growth- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- +249.5%
- FY2025 revenue growth
- -100.0%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | -100.0% |
| Q3 2025 | $0 | -100.0% |
| Q2 2025 | $0 | -100.0% |
| Q1 2025 | $0 | -100.0% |
| Q4 2024 | $7.5M | +1349.1% |
| Q3 2024 | $302K | -35.5% |
| Q2 2024 | $357K | -54.3% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2024)
PRAX's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
PRAX Revenue Analysis (2018–2025)
Current Revenue & Growth
As of June 23, 2026, Praxis Precision Medicines, Inc. (PRAX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
PRAX's historical revenue data shows various trends over time. Praxis Precision Medicines, Inc.'s highest annual revenue of $8.6 million was recorded in 2024.
Revenue by Segment
PRAX's revenue is primarily driven by License (77%), and Upfront Payment (23%). With over half of revenue concentrated in License, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including ACAD (+9.9% YoY), NRIX (+54.0% YoY), and ARVN (-79.1% YoY). Compare PRAX vs ACAD →
PRAX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PRAXCurrent | $0 | - | - | - | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 NRIX | $84M | +54.0% | +36.3% | -340.2% | |
 ARVN | $263M | -79.1% | +58.9% | -43.8% | |
 LGND | $268M | +51.2% | +10.4% | 17.6% | |
 OVID | $7M | +1199.6% | -10.5% | -585.2% |
PRAX Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | $-140,000 | - | $-326,198,000 | - |
| 2024 | $8.6M | +249.5% | $-143,860,000 | -1682.0% | $-200,165,000 | -2340.3% |
| 2023 | $2.4M | - | $-84,319,000 | -3445.8% | $-126,373,000 | -5164.4% |
| 2022 | $0 | - | $-154,440,000 | - | $-214,986,000 | - |
| 2021 | $0 | - | $0 | - | $-167,332,000 | - |
| 2020 | $0 | - | $0 | - | $-61,968,000 | - |
| 2019 | $0 | - | $-679,000 | - | $-35,789,000 | - |
| 2018 | $0 | - | $-1,000 | - | $-22,719,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRAX — Frequently Asked Questions
Quick answers to the most common questions about buying PRAX stock.
Is PRAX's revenue growth accelerating or slowing?
PRAX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PRAX's revenue history from 2018 to 2026?
Praxis Precision Medicines, Inc. (PRAX) revenue history spans 2018 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is PRAX's long-term revenue growth rate (CAGR)?
Praxis Precision Medicines, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for PRAX.
Why does PRAX's quarterly revenue fluctuate?
PRAX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Praxis Precision Medicines, Inc.'s revenue data from 2018 to 2026 shows full historical quarterly detail on this page.
How is PRAX's revenue distributed by segment?
PRAX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does PRAX's revenue compare to industry peers?
Praxis Precision Medicines, Inc. (PRAX) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.